264 related articles for article (PubMed ID: 31199983)
1. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma.
Tolbert VP; Dvorak CC; Golden C; Vissa M; El-Haj N; Perwad F; Matthay KK; Vo KT
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2031-2039. PubMed ID: 31199983
[TBL] [Abstract][Full Text] [Related]
2. High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
Jodele S; Dandoy CE; Myers K; Wallace G; Lane A; Teusink-Cross A; Weiss B; Davies SM
Bone Marrow Transplant; 2018 Oct; 53(10):1311-1318. PubMed ID: 29674658
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Schoettler M; Lehmann L; Li A; Ma C; Duncan C
Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
[TBL] [Abstract][Full Text] [Related]
4. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.
Laskin BL; Goebel J; Davies SM; Khoury JC; Bleesing JJ; Mehta PA; Filipovich AH; Paff ZN; Lawrence JM; Yin HJ; Pinkard SL; Jodele S
Bone Marrow Transplant; 2011 May; 46(5):682-9. PubMed ID: 20697372
[TBL] [Abstract][Full Text] [Related]
5. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
6. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
7. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
[TBL] [Abstract][Full Text] [Related]
8. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
[TBL] [Abstract][Full Text] [Related]
10. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Benítez Carabante MI; Bueno D; Alonso García L; López Torija I; Marsal J; Fernandez Navarro JM; Uria Oficialdegui ML; Panesso M; Molina B; Beléndez Bieler C; Palomo P; Pérez Martínez A; Diaz-de-Heredia C
Transplant Cell Ther; 2024 Jun; 30(6):601.e1-601.e13. PubMed ID: 38521410
[TBL] [Abstract][Full Text] [Related]
11. Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab.
Schoettler M; Duncan C; Lehmann L
Pediatr Transplant; 2019 May; 23(3):e13381. PubMed ID: 30828947
[TBL] [Abstract][Full Text] [Related]
12. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies.
Abusin GA; Abu-Arja R; Bajwa RPS; Horwitz EM; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28333416
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
Khosla J; Yeh AC; Spitzer TR; Dey BR
Bone Marrow Transplant; 2018 Feb; 53(2):129-137. PubMed ID: 28967899
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients.
Higham CS; Shimano KA; Melton A; Kharbanda S; Chu J; Dara J; Winestone LE; Hermiston ML; Huang JN; Dvorak CC
Pediatr Blood Cancer; 2022 May; 69(5):e29641. PubMed ID: 35253361
[TBL] [Abstract][Full Text] [Related]
15. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients.
Jodele S; Sabulski A
Expert Rev Hematol; 2021 Aug; 14(8):751-763. PubMed ID: 34301169
[TBL] [Abstract][Full Text] [Related]
16. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
[TBL] [Abstract][Full Text] [Related]
18. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
Jodele S; Laskin BL; Goebel J; Khoury JC; Pinkard SL; Carey PM; Davies SM
Transfusion; 2013 Mar; 53(3):661-7. PubMed ID: 22804695
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
[TBL] [Abstract][Full Text] [Related]
20. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
